Download full-text PDF |
Source |
---|
Neurosurgery
November 2024
Department of Neurological Surgery, University of Virginia, Charlottesville, Virginia, USA.
Drug Dev Res
September 2024
Pituitary Tumor Center, Department of Neurosurgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Nonfunctioning pituitary adenoma (NFPA) is one of the major subtypes of pituitary adenomas (PA) and its primary treatment is surgical resection. However, normal surgery fails to remove lesions completely and there remains in lack of frontline treatment, so the development of new drugs for NFPA is no doubt urgent. Oridonin (ORI) has been reported to have antitumor effects on a variety of tumors, but whether it could exhibit the same effect on NFPA requires to be further investigated.
View Article and Find Full Text PDFNeuro Oncol
November 2024
Department of Neurosurgery, Center of Pituitary Tumor, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Background: Managing nonfunctioning pituitary adenomas (NFPAs) is difficult due to limited drug treatments. Cabergoline's (CAB) effectiveness for NFPAs is debated. This study explores the role of HTR2B in NFPAs and its therapeutic potential.
View Article and Find Full Text PDFNephrol Nurs J
July 2024
Chief Operating Officer, National Dialysis Accreditation Commission (NDAC), Glen Ellyn, IL.
The importance of the Life Safety Code (LSC) cannot be understated. The LSC is composed of a set of components, measures, and protocols with the overarching goal of protecting and preserving human life. This article describes the LSC survey process in dialysis facilities.
View Article and Find Full Text PDFJ Neurosurg
September 2024
1Department of Neurological Surgery, University of Virginia, Charlottesville, Virginia.
Objective: Stereotactic radiosurgery (SRS) is used for the treatment of residual/recurrent nonfunctional pituitary adenoma (NFPA). The aim of this study was to evaluate the factors related to long-term tumor control and delayed endocrinopathies following SRS.
Methods: This retrospective, multicenter study included patients with recurrent/residual NFPA treated with single-fraction SRS; they were then divided into two arms.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!